a public good project by the
Synthesis
Company
of California

© 2026

Giuseppe Giardina | doi.page

0 works0 citations0 h-index

Giuseppe Giardina

Vita-Salute San Raffaele University(IT)Istituti di Ricovero e Cura a Carattere Scientifico(IT)Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele

Publications by Year

Research Areas

Neuropeptides and Animal Physiology, Receptor Mechanisms and Signaling, Pharmacological Receptor Mechanisms and Effects, Chemical Synthesis and Analysis, Cardiac, Anesthesia and Surgical Outcomes

Most-Cited Works

→ &#947;-Secretase Inhibitors and Modulators for the Treatment of Alzheimer's Disease: Disappointments and Hopes(2011)198 cited
→ A Randomized Trial of Intravenous Amino Acids for Kidney Protection(2024)147 cited
→ Modification of Nociception and Morphine Tolerance by the Selective Opiate Receptor-Like Orphan Receptor Antagonist (–)-cis-1-Methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5 H-benzocyclohepten-5-ol (SB-612111)(2004)147 cited
Catologue of the plants growing in Sicily(2007)
→ Nonpeptide Tachykinin Receptor Antagonists: I. Pharmacological and Pharmacokinetic Characterization of SB 223412, a Novel, Potent and Selective Neurokinin-3 Receptor Antagonist(1997)107 cited
→ Continuous vs Intermittent Meropenem Administration in Critically Ill Patients With Sepsis(2023)106 cited

→ Nonpeptide Tachykinin Receptor Antagonists. III. SB 235375, a Low Central Nervous System-Penetrant, Potent and Selective Neurokinin-3 Receptor Antagonist, Inhibits Citric Acid-Induced Cough and Airways Hyper-reactivity in Guinea Pigs(2002)

90 cited

→ Discovery of a Novel Class of Selective Non-Peptide Antagonists for the Human Neurokinin-3 Receptor. 1. Identification of the 4-Quinolinecarboxamide Framework(1997)79 cited

→ (2S)-1-(Arylacetyl)-2-(aminomethyl)piperidine derivatives: novel, highly selective .kappa. opioid analgesics(1991)77 cited

→ Nonpeptide Tachykinin Receptor Antagonists. II. Pharmacological and Pharmacokinetic Profile of SB-222200, a Central Nervous System Penetrant, Potent and Selective NK-3 Receptor Antagonist(2000)72 cited